Rating History for Stoke Therapeutics (STOK) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/5/2026 | Yatin Suneja | New Coverage | Buy (N/A) |
60.00 (N/A) |
33.79 (31.25) |
-7.52% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/5/2026 | Yatin Suneja | New Coverage | Buy (N/A) |
60.00 (N/A) |
33.79 (31.25) |
-7.52% | Details |